Our Company

Our Company

Established in Europe in 2009, we are a multinational group that operates internationally and enjoys a strong presence in the major pharmaceutical markets. mAbxience is also fully committed [...]

About Us

About Us

Dr. Sigman and his biochemist wife, Silvia Gold, founded mAbxience in 2009 as the biotechnology arm of the CHEMO Group, which the couple set up in 1977. Hugo [...]

mAbBLOG

The contribution of monoclonal antibodies in haematology

As we have said in previous posts on the social impact of biosimilars, we can now see that both the pharmaceutical industry and national health systems are [...]

+